CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 variant 6 is associated with prostate cancer growth and chemo-/radiotherapy response in vivo

Published:2020-03 Issue:2 Volume:388 Page:111850
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Ni Jie,Cheung Belamy B.,Beretov Julia,Duan Wei,Bucci Joseph,Malouf David,Graham Peter,Li Yong

Funder

Cancer Research Trust Fund at Cancer Care Centre

St. George Hospital

China Scholarship Council

Prostate and Breast Cancer Foundation

Publisher

Elsevier BV

Subject

Cell Biology

Reference38 articles.

1. Cancer statistics;Siegel;Ca - Cancer J. Clin.,2018

2. Radiosensitization in prostate cancer: mechanisms and targets;Palacios;BMC Urol.,2013

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N. Engl. J. Med.,2004

4. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N. Engl. J. Med.,2004

5. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors;Afify;Int. J. Biol. Mark.,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Stem Cells: Biology and Treatment Implications;International Journal of Molecular Sciences;2023-10-04

2. CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies;Frontiers in Immunology;2023-10-03

3. Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia;Frontiers in Oncology;2023-09-06

4. CD44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor;Expert Review of Molecular Diagnostics;2023-07-03

5. Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants;Biomedicines;2023-04-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3